| Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798) | 
|---|
| 05/06/2009 | CN101422584A Multifunctional health-care medicine bag and production method thereof | 
| 05/06/2009 | CN101422579A Traditional Chinese medicine preparation for treating oral ulcer | 
| 05/06/2009 | CN101422572A Chinese and Western synthesized medicine for treating gastropathy | 
| 05/06/2009 | CN101422557A Medicine for treating colitis | 
| 05/06/2009 | CN101422555A Preparation capable of defaecating, adjusting qi and blood, improving internal secretion and preventing senescence | 
| 05/06/2009 | CN101422549A Traditional Chinese medicine external preparation capable of improving ascites due to cirrhosis and preparation method thereof | 
| 05/06/2009 | CN101422540A Medicine for curing stomatocase | 
| 05/06/2009 | CN101422530A Traditional Chinese medicine for treating upper right front-tooth pyretic toothache | 
| 05/06/2009 | CN101422529A Preparation method of traditional Chinese medicine preparation | 
| 05/06/2009 | CN101422527A Traditional Chinese medicine oral liquid for treating poultry diarrhea | 
| 05/06/2009 | CN101422526A Traditional Chinese medicine oral liquid for treating poultry colibacillosis | 
| 05/06/2009 | CN101422525A Compound astragalus membranaceus powder and production method thereof | 
| 05/06/2009 | CN101422524A Traditional Chinese medicine oral liquid for treating livestock and poultry enteritis | 
| 05/06/2009 | CN101422523A Health-care preparation capable of alleviating a hangover and protecting the liver and preparation method thereof | 
| 05/06/2009 | CN101422522A Preparation method of traditional Chinese medicine preparation | 
| 05/06/2009 | CN101422521A Traditional Chinese medicine oral liquid for treating livestock and poultry diarrhea | 
| 05/06/2009 | CN101422513A Preparation method of total anthraquinone in Rhubarb for treating damp-heat type icterohepatitis | 
| 05/06/2009 | CN101422512A Traditional Chinese medicine oral liquid for treating poultry hepatic injury | 
| 05/06/2009 | CN101422511A Medicine for treating ulcerative colitis | 
| 05/06/2009 | CN101422502A Preparation method of dogwood extract containing ursolic acid | 
| 05/06/2009 | CN101422495A Comprehensive therapy method | 
| 05/06/2009 | CN101422494A Creat extract and medical use thereof | 
| 05/06/2009 | CN101422477A Compound apramycin sulfate injection | 
| 05/06/2009 | CN101422474A Use of magnesium isoglycyrrhizinate preparation for vein in treating skin disease | 
| 05/06/2009 | CN101422470A Remofovir orally disintegrating tablets and preparation method thereof | 
| 05/06/2009 | CN101422464A Compound fubennikao injection | 
| 05/06/2009 | CN101422438A Composite diisopropyiarmini dichloroacetas freeze-dry preparation without adjuvant and preparation technique thereof | 
| 05/06/2009 | CN101422424A Mycophenolic acid medicine implantation agent and preparation method and use thereof | 
| 05/06/2009 | CN100484933C Novel pyrazine compounds, their use in preparing medicament for treating diseases correlated with serotonin | 
| 05/06/2009 | CN100484569C Medicament for mobilizing pluripotent stem cells from tissue into peripheral blood | 
| 05/06/2009 | CN100484552C Health protection capsule | 
| 05/06/2009 | CN100484551C Xylitol green tea preparation for clearing mouth smell and preventing decayed tooth and its preparation process | 
| 05/06/2009 | CN100484548C Medicine for treating gastritis and its preparation method | 
| 05/06/2009 | CN100484544C Preparing method of gentian capsule for purging liver fire | 
| 05/06/2009 | CN100484543C Medicament composition for treating hepatitis, prepartion method and use | 
| 05/06/2009 | CN100484540C Glossy ganoderma polysaccharide and preparing method thereof | 
| 05/06/2009 | CN100484536C Capsule for treating enteritis and dysentery and its preparing process | 
| 05/06/2009 | CN100484535C Medicine for treating toothache | 
| 05/06/2009 | CN100484534C Application of marsilea in preparation of medicine for relieving alcoholism and hepatoprotection | 
| 05/06/2009 | CN100484525C Pantoprazole sodium freeze-dried powder injection and preparing method thereof | 
| 05/06/2009 | CN100484519C Ginseng and aconite tablet for injection use for treating qi vacuity and yang desertion and its preparation method | 
| 05/06/2009 | CN100484417C Health care bamboo salt and its preparing method | 
| 05/05/2009 | US7528226 TGFβ1-inhibitor peptides | 
| 05/05/2009 | US7528164 e.g. 2-Amino-4-(3-bromo-4,5-dimethoxyphenyl)-3-cyano-7-methyl-4H-pyrrolo [2,3-h]chromene; antiproliferative, antitumor, anticarcinogenic agent | 
| 05/05/2009 | US7528162 such as 3-(4-Chlorophenyl)-N'-((4-chlorophenyl)sulfonyl)-N-(piperidin-1-yl)-4-phenyl-4,5-dihydro-1H-pyrazole-1-carboxamidine, used as cannabinoid (CB1) receptor antagonists, for prophylaxis of psychological disorders | 
| 05/05/2009 | US7528156 Such as N-[2-(3-{[1-(3,4-dichlorobenzylpiperidinyl]aminohydroxypropoxy)phenyl]acetamide; antiinflammatory agents, antiarthritic agents; chronic obstructive pulmonary disease, asthma, multiple sclerosis | 
| 05/05/2009 | US7528154 Polyarylcarboxamides useful as lipid lowering agents | 
| 05/05/2009 | US7528152 synthetic analog of Hemiasterlin; anticarcinogenic agent; restenosis of blood vessels subject to traumas such as angioplasty and stenting; safe and effective, while retaining stability in biological media; exhibit low cytotoxicity to non-dividing normal cells | 
| 05/05/2009 | US7528124 1,3-dihydro-2H-indol-2-one derivative | 
| 05/05/2009 | US7528110 Anti-allergic complex molecules | 
| 05/05/2009 | US7527974 Preparing embryonic stem cells via nuclear transplantation; tissue engineering and the use of embryonic stem in diagnosis, prevention and treatment of cell proliferative, nervous system, muscular and bone disorders; tissue repair | 
| 05/05/2009 | US7527810 Oral immunology using plant product containing hepatitis surface antigen | 
| 05/05/2009 | CA2448281C Optical resolution of (1-benzyl-4-methylpiperidin-3-yl)-methylamine and the use thereof for the preparation of pyrrolo 2,3-pyrimidine derivatives as protein kinases inhibitors | 
| 05/05/2009 | CA2322953C Pyridine derivative and pharmaceutical containing the same | 
| 05/05/2009 | CA2267247C Heteroaryloxyethylamines as 5-ht1a ligands | 
| 05/05/2009 | CA2204747C New azo derivatives of 5-aminosalicylic acid | 
| 04/30/2009 | WO2009054793A1 Thiophene 1,2,4-triazole derivatives as modulators of mglur5 | 
| 04/30/2009 | WO2009054792A1 Aminopyridine derivatives as modulators of mglur5 | 
| 04/30/2009 | WO2009054791A1 Fused pyrrolidine 1,2,4-triazole derivatives as modulators of mglur5 | 
| 04/30/2009 | WO2009054790A1 Amide linked heteroaromatic derivatives as modulators of mglur5 | 
| 04/30/2009 | WO2009054789A1 1,2,3-triazole pyrrolidine derivatives as modulators of mglur5 | 
| 04/30/2009 | WO2009054787A1 1,2,4-triazole carboxylic acid derivatives as modulators of mglur5 | 
| 04/30/2009 | WO2009054786A1 1,2,4-triazole aryl n-oxides derivatives as modulators of mglur5 | 
| 04/30/2009 | WO2009054785A1 1,2,4-triazole ether derivatives as modulators of mglur5 | 
| 04/30/2009 | WO2009054737A1 Method of reducing greenhouse gas production | 
| 04/30/2009 | WO2009054483A1 Drug containing salusin-β | 
| 04/30/2009 | WO2009054454A1 Regulator for signaling of toll-like receptor, which comprises cathepsin inhibitor as active ingredient | 
| 04/30/2009 | WO2009053754A2 Novel crystalline forms | 
| 04/30/2009 | WO2009053750A2 Novel crystalline and amorphous forms | 
| 04/30/2009 | WO2009053733A2 Novel crystalline forms | 
| 04/30/2009 | WO2009053732A1 Novel salt | 
| 04/30/2009 | WO2009053268A1 Novel phenyl-substituted piperazino-dihydrothienopyrimidines | 
| 04/30/2009 | WO2009032885A3 Piperidinylamino-thieno[2,3-d] pyrimidine compounds for treating fibrosis | 
| 04/30/2009 | WO2009027985A3 Fiber/granule complex for the treatment of the gi tract | 
| 04/30/2009 | WO2009005838A3 Process for the preparation of a non-corrosive base solution and methods of using same | 
| 04/30/2009 | WO2008138605A3 Method for producing n-methylnaltrexone bromide | 
| 04/30/2009 | WO2008102017A3 Food comprising polyunsaturated fatty acids for the prevention of chronic diseases | 
| 04/30/2009 | WO2008061209A3 G protein coupled receptors and uses thereof | 
| 04/30/2009 | WO2004092199A3 Method for identifying modulators of g protein coupled receptor signaling | 
| 04/30/2009 | US20090111879 Administering N-(2,6-Dichlorobenzoyl)-4-(2,6-dimethoxy-4-methoxymethylphenyl)-L-phenylalanine ethyl ester for therapy of asthma, inflammatory bowel disease, rheumatoid arthritis and atopic dermatitis | 
| 04/30/2009 | US20090111857 1,2,4-triazole ether derivatives as modulators of mglur5 | 
| 04/30/2009 | US20090111856 Parenteral Formulation Comprising Proton Pump Inhibitor Sterilized in its Final Container by Ionizing Radiation | 
| 04/30/2009 | US20090111854 1,2,4-triazole aryl n-oxides derivatives as modulators of mglur5 | 
| 04/30/2009 | US20090111843 Therapeutic or Prophylactic Agent for Functional Bowel Disorder | 
| 04/30/2009 | US20090111833 Injectable meclizine formulations and methods | 
| 04/30/2009 | US20090111825 Thiophene 1,2,4-triazole derivatives as modulators of mglur5 | 
| 04/30/2009 | US20090111823 Aminopyridine derivatives as modulators of mglur5 | 
| 04/30/2009 | US20090111822 1,2,3-triazole pyrrolidine derivatives as modulators of mglur5 | 
| 04/30/2009 | US20090111821 Amino 1,2,4-triazole derivatives as modulators of mglur5 | 
| 04/30/2009 | US20090111811 1,2,4-triazole carboxylic acid derivatives as modulators of mglur5 | 
| 04/30/2009 | US20090110759 Pharmaceutical Composition for Use as a Laxative | 
| 04/30/2009 | US20090110727 Extended release compositions of proton pump inhibitors | 
| 04/30/2009 | US20090110663 Method for treatment of bowel disorders | 
| 04/30/2009 | US20090110655 Prophylactic and/or therapeutic drug for nonalcoholic steatohepatitis | 
| 04/30/2009 | DE102007063660A1 Injektionseinrichtung zur Injektion in biologisches Gewebe und Injektionsdepot Injection means for injecting into biological tissue and injection depot | 
| 04/30/2009 | DE102007057231A1 Verwendung eines potenten Produktes, extrahiert aus Wurzelstöcken von Zingiber officinale zur Behandlung einer Krankheit, die mit Helicobacter pylori in Verbindung steht Use of a potent product extracted from rhizomes of Zingiber officinale for treating a disease that is associated with Helicobacter pylori | 
| 04/30/2009 | DE102005056558B4 Kombinationspräparate enthaltend physiologische Zellmembran-Bestandteile Combination products containing physiological cell membrane components | 
| 04/30/2009 | CA2702447A1 New phenyl-substituted piperazino-dihydrothienopyrimidines | 
| 04/29/2009 | EP2053041A2 1,3,5-Trisubstituted 2(1H)-pyridones as AMPA receptor inhibitors useful for the treatment of eg Parkinson's disease | 
| 04/29/2009 | EP2053038A1 Aminoalcohol derivative and immunosuppressant containing the same as an active ingredient |